Page 55 - F. Cell biology
P. 55

Targeting both apoptosis and necroptosis by resveratrol and docetaxel
            induces synergistic cytotoxicity of prostate carcinoma cells
                                     Yoon-Jin Lee and Sang-Han Lee

   Department of Biochemistry, College of Medicine, Soonchunhyang University, Cheonan 31151, Republic of Korea

                   BACKGROUND                                                  AIM

   Androgen deprivation therapy is one of the main treatment  The present study was performed to investigate the
   options for patients with early-stage androgen-dependent  efficacy of resveratrol during combination treatment
   prostate cancer, but almost all patients proceed to develop  with the anticancer drug docetaxel in prostate
   androgen-independent prostate cancer in a few years.   carcinoma LNCaP cells, including details of factors
   Progress to an incurable and irreversible androgen-    related to detailed cell death mechanisms.
   independent stage remains a major obstacle to effective
   treatment, and a strong need for alternative treatment
   strategies is being emphasized.

                                                METHODS

   1. Cell lines: Prostate cancer LNCaP cells             2. Cell viability assay: MTT assay
   3. Annexin V-PE binding assay                          4. Cell cycle analysis
   5. Western blot analysis                               6. Measurement of intracellular ROS
   7. Spheroid culture and viability assay                8. Spheroid staining
   9. Statistical analysis

                                                RESULTS








































          CONCLUSION                         REFERENCES                   ACKNOWLEDGEMENTS

   We report resveratrol as an adjuvant  1. Ko JH, Sethi G, Um JY, Shanmugam MK,  This research was supported by the Basic
                                      Arfuso F, Kumar AP, Bishayee A, Ahn KS. The
   drug  candidate  for  improving  the  role of resveratrol in cancer therapy. Int J Mol Sci  Science Research Program through the
                                                                          National Research Foundation (NRF) of
   outcome of treatment in docetaxel  2017;18:2589.                       Korea, funded by the Ministry of Education
   therapy.  Although  the  underlying  2. Takashina M, Inoue S, Tomihara K, Tomita K,  (No. NRF-2017R1D1A3B04031891).
   mechanisms of necroptosis should be  Hattori K, Zhao QL, Suzuki T, Noguchi M, Ohashi
                                      W, Hattori Y. Different effect of resveratrol to Contact information
   investigated      comprehensively,  induction of apoptosis depending on the type of
   simultaneously targeting apoptosis and  human cancer cells. Int J Oncol 2017;50:787-97.  Corresponding Author: Yoon-Jin Lee,
   necroptosis in cancer therapy might  3. Hu S, Li X, Xu R, Ye L, Kong H, Zeng X, Wang  Tel, 82-41-570-2440, Fax, 82-41-579-
   provide very promising opportunities for  H, Xie W. The synergistic effect of resveratrol in  6080, Email, leeyj@sch.ac.kr
                                      combination with cisplatin on apoptosis via
   new drug development.              modulating  autophagy in  A549  cells.  Acta
                                      Biochim Biophys Sin (Shanghai) 2016;48:528-35.
   50   51   52   53   54   55   56   57   58   59   60